4/17
04:05 pm
adpt
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
Medium
Report
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
4/4
12:33 pm
adpt
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at BTIG Research from $6.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at BTIG Research from $6.00 to $5.00. They now have a "buy" rating on the stock.
4/2
04:24 pm
adpt
Adaptive Biotechnologies announces conclusion of strategic review, expects Q1 revenue between $41M and $43M [Seeking Alpha]
High
Report
Adaptive Biotechnologies announces conclusion of strategic review, expects Q1 revenue between $41M and $43M [Seeking Alpha]
4/2
04:17 pm
adpt
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue [Yahoo! Finance]
High
Report
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue [Yahoo! Finance]
4/2
04:05 pm
adpt
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
Medium
Report
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
3/27
08:30 am
adpt
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
Low
Report
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
3/14
09:26 am
adpt
SWEETWATER PRIVATE EQUITY HONORS GEOFFREY CHAIKEN, CO-FOUNDER AND CEO OF BLINK HEALTH [Yahoo! Finance]
Low
Report
SWEETWATER PRIVATE EQUITY HONORS GEOFFREY CHAIKEN, CO-FOUNDER AND CEO OF BLINK HEALTH [Yahoo! Finance]
2/25
11:42 am
adpt
Adaptive Biotechnologies: A Post Earnings Assessment [Seeking Alpha]
Medium
Report
Adaptive Biotechnologies: A Post Earnings Assessment [Seeking Alpha]
2/22
04:05 pm
adpt
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
Medium
Report
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
2/22
12:14 pm
adpt
In Vitro Diagnostics Markets Revolutionized by Artificial Intelligence and Multiplex Testing: A Comprehensive 2023-2027 Forecast [Yahoo! Finance]
Low
Report
In Vitro Diagnostics Markets Revolutionized by Artificial Intelligence and Multiplex Testing: A Comprehensive 2023-2027 Forecast [Yahoo! Finance]
2/16
01:36 pm
adpt
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $11.00 to $5.00. They now have a "neutral" rating on the stock.
Low
Report
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $11.00 to $5.00. They now have a "neutral" rating on the stock.
2/15
10:26 am
adpt
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/15
10:16 am
adpt
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $11.00 to $8.00. They now have an "overweight" rating on the stock.
Medium
Report
Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $11.00 to $8.00. They now have an "overweight" rating on the stock.
2/14
05:24 pm
adpt
Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment [Yahoo! Finance]
High
Report
Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment [Yahoo! Finance]
2/14
04:23 pm
adpt
Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M [Seeking Alpha]
Medium
Report
Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M [Seeking Alpha]
2/14
04:18 pm
adpt
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/14
04:05 pm
adpt
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
Low
Report
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
2/13
02:40 am
adpt
Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 [Yahoo! Finance]
Medium
Report
Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 [Yahoo! Finance]
2/12
11:10 am
adpt
Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS [Yahoo! Finance]
Low
Report
Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS [Yahoo! Finance]
1/31
04:11 am
adpt
Therapeutic Drug Monitoring Pipeline Report Highlights Development Phases, Clinical Trials, and Key Players in 2023 [Yahoo! Finance]
Medium
Report
Therapeutic Drug Monitoring Pipeline Report Highlights Development Phases, Clinical Trials, and Key Players in 2023 [Yahoo! Finance]
1/29
04:05 pm
adpt
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
Medium
Report
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
1/22
06:46 pm
adpt
Next Generation Sequencing (NGS) Tests Pipeline Analysis Report, 2023 and Beyond: Stages of Development, Segments, Region & Countries, Regulatory Path and Key Companies [Yahoo! Finance]
High
Report
Next Generation Sequencing (NGS) Tests Pipeline Analysis Report, 2023 and Beyond: Stages of Development, Segments, Region & Countries, Regulatory Path and Key Companies [Yahoo! Finance]